Stereoselective pharmacokinetics of ketorolac in children, adolescents and adults

被引:18
作者
Hamunen, K
Maunuksela, EL
Sarvela, J
Bullingham, RES
Olkkola, KT
机构
[1] Univ Helsinki, Ctr Hosp, Toolo Hosp, Dept Anaesthesia, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Dept Anaesthesia, Helsinki, Finland
[3] Univ Helsinki, Hosp Eye, Helsinki, Finland
[4] Syntex Med Res, Maidenhead, Berks, England
关键词
adults; children; enantiomers; ketorolac tromethamine; pharmacokinetics;
D O I
10.1034/j.1399-6576.1999.431012.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Previous pharmacokinetic studies on racemic ketorolac using nonstereoselective analytical methods have indicated that the plasma clearance of ketorolac is higher and the volume of distribution greater in children than in adults. The aim of this study was to study the stereoselective pharmacokinetics of racemic ketorolac in children, adolescents and adults. Methods: 18 children (6-11 yrs), 18 adolescents (12-17 yrs) and 18 adults (18-44 yrs) participated in the study. At the end of eye surgery they were given intravenous racemic ketorolac tromethamine 0.5 mg/kg. Plasma samples were assayed for (R)- and (S)-ketorolac with high-pressure liquid chromatography. Clearance (CL), volume of distribution at steady state (V-ss) and elimination (V-z) and elimination half-life (t(1/2,z)) were calculated with standard methods. Incidence of side-effects were recorded. Results: CL, V-ss, V-z and t(1/2,z) were higher (P < 0.05) for (S)-ketorolac than for the (R)-enantiomer. V-ss of the active (S)-enantiomer was higher in children than in adolescents (P < 0.05) and adults (P < 0.001) but the values for CL were similar. Due to the higher volume of distribution, t(1/2,z) was also higher in children than in adults. The pharmacokinetics of the (R)-enantiomer were essentially unaffected by age. Conclusion: On a pharmacokinetic basis, the maintenance dose requirements of ketorolac are similar in children, adolescents and adults.
引用
收藏
页码:1041 / 1046
页数:6
相关论文
共 17 条
[1]   CLINICAL PHARMACOKINETICS OF KETOROLAC TROMETHAMINE [J].
BROCKS, DR ;
JAMALI, F .
CLINICAL PHARMACOKINETICS, 1992, 23 (06) :415-427
[2]  
Gibaldi M. P., 1982, PHARMACOKINETICS
[3]  
GUZMAN A, 1986, J MED CHEM, V29, P589
[4]   THE PHARMACOKINETICS OF KETOROLAC ENANTIOMERS FOLLOWING INTRAMUSCULAR ADMINISTRATION OF THE RACEMATE [J].
HAYBALL, PJ ;
WROBEL, J ;
TAMBLYN, JG ;
NATION, RL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (01) :75-78
[5]   PHARMACOKINETICS OF SINGLE-DOSE ORAL AND INTRAMUSCULAR KETOROLAC TROMETHAMINE IN THE YOUNG AND ELDERLY [J].
JALLAD, NS ;
GARG, DC ;
MARTINEZ, JJ ;
MROSZCZAK, EJ ;
WEIDLER, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) :76-81
[7]   PHARMACOKINETICS OF KETOROLAC AND P-HYDROXYKETOROLAC FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATION OF KETOROLAC TROMETHAMINE [J].
JUNG, D ;
MROSZCZAK, EJ ;
WU, A ;
LING, TL ;
SEVELIUS, H ;
BYNUM, L .
PHARMACEUTICAL RESEARCH, 1989, 6 (01) :62-65
[8]   PHARMACOKINETICS OF KETOROLAC TROMETHAMINE IN HUMANS AFTER INTRAVENOUS, INTRAMUSCULAR AND ORAL-ADMINISTRATION [J].
JUNG, D ;
MROSZCZAK, E ;
BYNUM, L .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (04) :423-425
[9]   COMPARISON OF INTRAVENOUS KETOROLAC WITH MORPHINE FOR POSTOPERATIVE PAIN IN CHILDREN [J].
MAUNUKSELA, EL ;
KOKKI, H ;
BULLINGHAM, RES .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (04) :436-443
[10]   Chiral kinetics and dynamics of ketorolac [J].
Mroszczak, E ;
Combs, D ;
Chaplin, M ;
Tsina, I ;
Tarnowski, T ;
Rocha, C ;
Tam, Y ;
Boyd, A ;
Young, J ;
Depass, L .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (06) :521-539